Home/Filings/4/0001104659-21-083662
4//SEC Filing

DST Capital LLC 4

Accession 0001104659-21-083662

CIK 0001563665other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 7:30 PM ET

Size

8.5 KB

Accession

0001104659-21-083662

Insider Transaction Report

Form 4
Period: 2021-06-17
Transactions
  • Purchase

    Common Stock

    2021-06-17$2.00/sh+150,000$300,0003,150,000 total
  • Purchase

    Warrant (right to buy)

    2021-06-17+75,00075,000 total
    Exercise: $2.00From: 2021-06-17Exp: 2026-06-17Common Stock (75,000 underlying)
Holdings
  • Common Stock

    (indirect: Owned by sole member of reporting person)
    30,722
Footnotes (1)
  • [F1]On June 17, 2021, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 150,000 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 75,000 shares of common stock with an exercise price of $2.00 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $300,000.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001727656

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 7:30 PM ET
Size
8.5 KB